Director/PDMR Shareholding- Replacement

RNS Number : 2559P

GlaxoSmithKline PLC

16 February 2016

 

The following amendment has been made to the Director/PDMR Shareholding announcement released on 16 February 2016 at 16:16 under RNS No 2472P.

Transaction date for Ordinary Shares changed from 12 February to 15 February 2016.

All other details remain unchanged.

The full amended text is shown below.

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial   Responsibility or Connected Persons

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of a Person Discharging Managerial Responsibilities' ('PDMR') Connected Person in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £14.06 per Ordinary Share on 15 February 2016 to meet tax liabilities following the vesting of awards granted in 2012 under the GlaxoSmithKline 2009 Performance Share Plan ('PSP').

Name of PDMR	Name of Connected Person	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Mr P Thomson	Mrs K Thomson	633

The table below sets out changes in the interests of a Director's Connected Person in the American Depositary Shares ('ADS') of GlaxoSmithKline plc arising from the withholding of ADS at a fair market value price of $39.15 per ADS on 12 February 2016 to meet tax liabilities following the vesting of an award granted in 2012 under PSP.

Name of Director	Name of Connected Person	Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award
Dr M Slaoui	Dr K Slaoui	386

The Company and the above individual were advised of this transaction on 16 February 2016.      

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

16 February 2016

 

END

 

 

RDSGGUGPPUPQGMQ